Vaxess Technologies, Inc

Showcase Sponsor

Vaxess Technologies is a Boston-based preclinical stage company developing next-generation vaccines and immunotherapies on the MIMIX sustained-dermal delivery platform. The MIMIX microneedle combines ease of administration with dramatic efficacy enhancements enabled by the "mimicry" of natural infections through sustained release. In addition to advancing a self-administered, shelf-stable, and highly potent influenza vaccine in-house, the company has outstanding partnerships with a number of leading vaccine and biopharmaceutical companies. Vaxess has raised more than $15M from a variety of sources including venture capital and grant financing.